HIGHLIGHTS
- who: SRC family kinases et al. from the Department of Experimental Medicine, Sapienza University of Rome, viale Regina Elena , have published the article: Molecular Sciences, in the Journal: (JOURNAL)
- what: The aim of this study is to search for a suitable carrier that could improve the bioavailability of a small interfering molecule, known to be active on neuroblastoma cell growth and migration.
- how: This result is in line with the slight increase (8%) of cells in pre-G1 phase treated with 2 μg/mL GO2020 for 21 24 6430 h compared with untreated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.